Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Bellovin · SciRah

Researcher profile · Semantic Scholar

D. Bellovin

Share profile

D. Bellovin — researcher profile on SciRah

h-index: 16
Works: 52
Citations: 1,900

Most-cited papers

Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma.
R. Bates, D. Bellovin, Courtney Brown, E. Maynard +5 more
2005Journal of Clinical Investigation394 citations Open access
Semantic Scholar
MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells
B. Altman, An-Nie L. Hsieh, Arjun Sengupta, Saikumari Y Krishnanaiah +16 more
2015Cell Metabolism273 citations Open access
Semantic Scholar
MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism
Emelyn H. Shroff, L. Eberlin, Vanessa M. Dang, Arvin M. Gouw +11 more
2015Proceedings of the National Academy of Sciences of the United States of America249 citations Open access
Semantic Scholar
Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease.
D. Bellovin, R. Bates, A. Muzikansky, D. Rimm +1 more
2005Cancer Research178 citations Open access
Semantic Scholar
MYC Phosphorylation, Activation, and Tumorigenic Potential in Hepatocellular Carcinoma are Regulated by HMG-CoA Reductase
Zhongwei Cao, H. Fan-Minogue, D. Bellovin, Aleksey Yevtodiyenko +4 more
2011Cancer Research176 citations Open access
Semantic Scholar
SIRT1 and c-Myc Promote Liver Tumor Cell Survival and Predict Poor Survival of Human Hepatocellular Carcinomas
K. Jang, Sang Jae Noh, N. Lehwald, G. Tao +5 more
2012PLoS ONE110 citations Open access
Semantic Scholar
Combined Inactivation of MYC and K-Ras Oncogenes Reverses Tumorigenesis in Lung Adenocarcinomas and Lymphomas
P. Tran, Alice C. Fan, Pavan K. Bendapudi, Shan Koh +8 more
2008PLoS ONE94 citations Open access
Semantic Scholar
MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity
R. Dhanasekaran, V. Baylot, Minsoon Kim, Sibu P. Kuruvilla +14 more
2020eLife62 citations Open access
Semantic Scholar
Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancer
H. Xiang, Ab Chan, A. Ahene, D. Bellovin +7 more
2021mAbs54 citations Open access
Semantic Scholar
Hepatotoxin-Induced Changes in the Adult Murine Liver Promote MYC-Induced Tumorigenesis
Shelly Beer, K. Komatsubara, D. Bellovin, Masashi Kurobe +2 more
2008PLoS ONE46 citations Open access
Semantic Scholar
Tumor Dormancy, Oncogene Addiction, Cellular Senescence and Self-Renewal Programs
D. Bellovin, B. Das, D. Felsher
2013Advances in Experimental Medicine and Biology44 citations Open access
Semantic Scholar
Characterization of MYC-Induced Tumorigenesis by in situ Lipid Profiling
Richard H. Perry, D. Bellovin, Emelyn H. Shroff, Ali I. Ismail +3 more
2013Analytical Chemistry38 citations Open access
Semantic Scholar
MYC ASO Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse Models of HCC and RCC
R. Dhanasekaran, J. Park, Alekesey Yevtodiyenko, D. Bellovin +8 more
2020Molecular Therapy: Nucleic Acids31 citations Open access
Semantic Scholar
A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma
E. van Brummelen, E. Levchenko, M. Dómine, Dean A. Fennell +18 more
2019Investigational new drugs25 citations Open access
Semantic Scholar
MYC oncogene elicits tumorigenesis associated with embryonic, ribosomal biogenesis, and tissue-lineage dedifferentiation gene expression changes
Delaney K. Sullivan, Anja Deutzmann, Josiah Yarbrough, Maya S Krishnan +6 more
2022Oncogene21 citations Open access
Semantic Scholar
Abstract 5446: FPA144: A therapeutic antibody for treating patients with gastric cancers bearing FGFR2 gene amplification
A. T. Gemo, Amit M. Deshpande, Servando Palencia, D. Bellovin +5 more
201420 citations
Semantic Scholar
Low-level shRNA Cytotoxicity Can Contribute to MYC-induced Hepatocellular Carcinoma in Adult Mice.
Shelly Beer, D. Bellovin, Joyce S. Lee, K. Komatsubara +8 more
2025Molecular Therapy13 citations Open access
Semantic Scholar
Noncanonical Roles of the Immune System in Eliciting Oncogene Addiction
S. Casey, D. Bellovin, D. Felsher
2013Current Opinion in Immunology13 citations Open access
Semantic Scholar
FPA144, a humanized monoclonal antibody for both FGFR2-amplified and nonamplified, FGFR2b-overexpressing gastric cancer patients.
K. L. Pierce, Amit M. Deshpande, Bradley A. Stohr, Abigael T. Gemo +10 more
201412 citations
Semantic Scholar
ZL-1211 Exhibits Robust Antitumor Activity by Enhancing ADCC and Activating NK Cell–mediated Inflammation in CLDN18.2-High and -Low Expressing Gastric Cancer Models
Hiroyasu Konno, Tracey Lin, Ren-Yi Wu, Xin-Chuan Dai +17 more
2022Cancer Research Communications11 citations Open access
Semantic Scholar
Low-level shRNA cytotoxicity can contribute to MYC-induced hepatocellular carcinoma in adult mice.
Shelly Beer, D. Bellovin, Joyce S. Lee, K. Komatsubara +8 more
2010Molecular Therapy10 citations Open access
Semantic Scholar
cmFPA008, an anti-mouse CSF-1R antibody, combines with multiple immunotherapies to reduce tumor growth in nonclinical models
D. Bellovin, Nebiyu Wondyfraw, A. Levin, D. DeNardo +2 more
2015Journal of Immunotherapy for Cancer6 citations Open access
Semantic Scholar
Abstract 2845: Expression of FGFR2b in gastric cancer as measured by immunohistochemistry with a highly specific monoclonal antibody
Amit M. Deshpande, Servando Palencia, D. Bellovin, A. T. Gemo +4 more
20145 citations
Semantic Scholar
Abstract 5449: FP-1039/GSK3052230, an FGF ligand trap, enhances VEGF antagonist therapy in preclinical models of RCC and HCC
D. Bellovin, Servando Palencia, K. Hestir, Ernestine Lee +4 more
20143 citations
Semantic Scholar
Abstract 2953: Rev-erbα modulates Myc-driven cancer cell growth and altered metabolism
B. Altman, An-Nie L. Hsieh, Arvin M. Gouw, Zachary E. Stine +11 more
20143 citations
Semantic Scholar
6PDFPA150, a novel B7-H4 therapeutic antibody with checkpoint blockade and ADCC activities
C. Kaplan, Derrick Houser, F. Kemp, N. Nielson +8 more
20172 citations Open access
Semantic Scholar
Abstract LB-236: Preclinical efficacy of targeting FGF autocrine signaling in mesothelioma with the FGF ligand trap, FP-1039/GSK3052230
M. D. De Young, C. Sherk, Maureen R. Bleam, M. Barnette +7 more
20142 citations
Semantic Scholar
Abstract 4616: Oncogenic c- and N-Myc disrupt circadian rhythm.
B. Altman, An-Nie L. Hsieh, Arvin M. Gouw, Anand Venkataraman +6 more
20132 citations
Semantic Scholar
Abstract 3590: ZL-1218, a novel anti-CCR8 antibody, exerts potent antitumor effect by depleting intratumoral regulatory T cells
Jing Zhang, Wenhua Shi, Min Chen, Xin-Chuan Dai +11 more
2022Cancer Research1 citations
Semantic Scholar
Abstract 2594: Discovery and characterization of ZL-2201, a potent, highly-selective, and orally bioavailable small-molecule DNA-PK inhibitor
Shruti Lal, Bee-Chun Sun, Yuping Chen, Tom Huang +9 more
2022Cancer Research1 citations
Semantic Scholar
Abstract 1203: ZL-1211 exhibits broad anti-tumor activity in CLDN18.2 high- and low-expressing models
Hiroyasu Konno, Yong Li, X. Dai, Bee-Chun Sun +16 more
2021Experimental and Molecular Therapeutics1 citations
Semantic Scholar
Abstract 1599: Antibody-based inhibition of CSF-1R as a component of combination immunotherapy in preclinical models
D. Bellovin, Nebiyu Wondyfraw, Barbara Sennino, Quinn M. Walker +6 more
20171 citations
Semantic Scholar
TM-06MYC AND MYCN DISRUPTION OF THE MOLECULAR CLOCK IN CANCER CELLS
An-Nie L. Hsieh, B. Altman, Zachary E. Stine, Arvin M. Gouw +12 more
20141 citations Open access
Semantic Scholar
Abstract 2975: Transgenic mouse model of Twist1-induced metastasis reveals genes highly prognostic for human hepatocellular carcinoma
D. Bellovin, P. Tran, S. Adam, A. Gentles +2 more
20121 citations
Semantic Scholar
Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK Inhibitor
Shruti Lal, Neil H. Bhola, Bee-Chun Sun, Yuping Chen +10 more
2023Cancer Research Communications0 citations Open access
Semantic Scholar
Abstract 621: ZL-1211 exhibits robust anti-tumor activity by enhancing ADCC and activating innate and adaptive immunity in CLDN18.2-high and -low expressing gastric cancer models
Hiroyasu Konno, Tracey Lin, Bee-Chun Sun, Ren-Yi Wu +4 more
2022Cancer Research0 citations
Semantic Scholar
Transcriptional activation of integrin beta6 during the epithelial- Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma aggressive c
Richard C. Bates, D. Bellovin, Courtney Brown, E. Maynard +5 more
20220 citations
Semantic Scholar
Abstract 498: ZL-1201, a differentiated CD47 therapeutic antibody with improved hematological safety profile
B. Wan, Xu Fang, Shou Li, Wenhua Shi +14 more
2021Clinical research0 citations
Semantic Scholar
Author response: MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity
R. Dhanasekaran, V. Baylot, Minsoon Kim, Sibu P. Kuruvilla +14 more
20190 citations Open access
Semantic Scholar
Combination therapy for cancer using anti-gitr antibodies
Susannah D. Barbee, D. Bellovin, L. Borges
20180 citations
Semantic Scholar
Combination anti-csf1r and anti-pd-1 antibody combination therapy for pancreatic cancer
K. Lewis, S. Perna, M. Carleton, Ke Xu +10 more
20180 citations
Semantic Scholar
Abstract 613: Development of FPA154, a novel tetravalent anti-GITR antibody, for the treatment of solid tumors
Susannah D. Barbee, Amanda L. C. Chen, Susan B. Johnson, D. Bellovin +10 more
20170 citations
Semantic Scholar
GGNBP2servesasacriticalnuclearnegativeregulatorofSTAT3- mediatedgeneexpressionandtumorigenesis. depends on PI3K-signalling
P. Vitiello, G. Martini, C. Cardone, D. Ciardiello +31 more
20170 citations
Semantic Scholar
Identification of a novel immune checkpoint regulator and potential therapeutic antibody target in oncology
Nathan A. Sallee, A. Karasyov, D. Bellovin, Ryan Liang +8 more
2015Journal of Immunotherapy for Cancer0 citations Open access
Semantic Scholar
Identification of novel immune regulators of tumor growth using RIPPS screening in vivo
Thomas J. Brennan, D. Bellovin, Jacqueline de la Torre, Nebiyu Wondyfraw +3 more
2015Journal of Immunotherapy for Cancer0 citations Open access
Semantic Scholar
Abstract 1419: Oncogenic Myc disrupts NAMPT circadian oscillation in mouse hepatocellular carcinoma cell line
An-Nie L. Hsieh, B. Altman, Anand Venkataraman, D. Bellovin +3 more
20140 citations
Semantic Scholar
Twist1 Induces the Step-Wise Malignant Progression of Liver Cancer in Transgenic Mice Revealing a Prognostic 19-Gene Signature for Humans
P. Tran, D. Bellovin, S. Adam, A. Gentles +6 more
20130 citations Open access
Semantic Scholar
Abstract LB-313: Development of a novel anti-MYC therapeutic with efficacy against liver and kidney cancers.
D. Bellovin, Aleksey Yevtodiyenko, S. Adam, Hanan Fernando +3 more
20130 citations
Semantic Scholar
Twist1 Overexpression Induces Increased Tumor Cell Aggressiveness and Resistance to Sorafenib in Hepatocellular Carcinoma Cells
A. Wild, D. Bellovin, S. Chettiar, N. Gandhi +6 more
20130 citations Open access
Semantic Scholar
Therapeutics , Targets , and Chemical Biology MYCPhosphorylation , Activation , and Tumorigenic Potential in Hepatocellular Carcinoma Are Regulated by HMG-CoA Reductase
Zhongwei Cao, H. Fan-Minogue, D. Bellovin, Aleksey Yevtodiyenko +4 more
20110 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Felsher×23
Invite
D. Felsher — researcher profile on SciRah
Servando Palencia×7
Invite
Servando Palencia — researcher profile on SciRah
Thomas J. Brennan×7
Invite
Thomas J. Brennan — researcher profile on SciRah
Arvin M. Gouw×6
Invite
Arvin M. Gouw — researcher profile on SciRah

×6

Invite

C. Dang — researcher profile on SciRah

Invite

S. Adam — researcher profile on SciRah

Invite

P. Tran — researcher profile on SciRah

Bee-Chun Sun×6

Invite

Bee-Chun Sun — researcher profile on SciRah

Invite

B. Altman — researcher profile on SciRah

An-Nie L. Hsieh×5

Invite

An-Nie L. Hsieh — researcher profile on SciRah

Anand Venkataraman×5

Invite

Anand Venkataraman — researcher profile on SciRah

J. Hogenesch×5

Invite

J. Hogenesch — researcher profile on SciRah